IN PICTURES: Two decades of HIV in South Africa
We reflect in pictures South Africa’s journey in the struggle against HIV since 2000.
In-depth: What contraceptives are available in SA and which ones are most popular?
There are a variety of tools available today to prevent pregnancy including pills, intrauterine devices, subdermal implants, injections, condoms, male and female sterilisation, and emergency contraception. Statistics suggest that people in South Africa do, in principle at least, have access to and are aware of these contraceptive methods, albeit not at the desired levels. Elna Schütz looks at what contraceptive methods are available and makes some surprising discoveries along the way about which ones are most popular.
In-Depth: Hypertension – South Africa’s “silent killer”
It is estimated that around 45% of men and 48% of women older than 15 years have high blood pressure (hypertension) in South Africa and only about 19% of men and 29% of women who have this condition are aware that they have it. Elri Voigt unpacks the state of hypertension in the country and how it is diagnosed and treated.
Concerns over rise in acute psychiatric admissions in Western Cape
There has been an increase in the number of acute psychiatric admissions in the Western Cape since June, adding to the existing pressure on bed capacity in the province’s hospitals. Tiyese Jeranji unpacks the numbers and the provincial health department’s plans to address them.
Forty years on, HIV still taking a toll on young people
“Driving a fast car”; “getting the top three letters”; or “playing the lotto” – nearly 40 years from when HIV was first described, the virus is still a thing of euphemism and stigma. It’s also still infecting at least 4 000 people a day around the world, most of them young people, especially girls and young women. Ufrieda Ho reports.
INTERVIEW: Dr Thembisile Xulu on a year at the head of SANAC
On World AIDS Day, Dr Thembisile Xulu, CEO of the South African AIDS Council will share a podium with Deputy President David Mabuza for the country’s official commemoration event in Limpopo. Bienne Huisman spoke to her about how she settled into the CEO role and what keeps her busy.
Are two medicines instead of three the future of HIV treatment?
One of the biggest breakthroughs in HIV treatment in the 1990s came when three different antiretrovirals were used together, suppressing viral replication in multiple ways and preventing the development of drug resistance. Now, trials are showing that certain combinations of just two antiretrovirals might be as good as three, potentially bringing an end to a quarter of a century of triple therapy dominance. Elri Voigt reports.
Opinion: We should make it much easier for people to start and stay on HIV treatment
The top priority in our HIV programme should be to make it as easy as possible for people to start and stay on treatment. Yet, as a number of provincial reports released this year by community monitoring group Ritshidze have shown, there are many healthcare system factors that work directly against this objective. Spotlight editor Marcus Low considers some of the potential solutions.
OPINION: How to capitalise on the opportunity of COVID-19 vaccination sites
To combat COVID-19, our country has been able to move millions of people through vaccination sites each month, creating a potential ‘one-stop shop’ for vital health check-ups. In this, healthcare workers have an unprecedented opportunity to reach people they may not otherwise have access to, such as those living with HIV, writes Dhirisha Naidoo.
Opinion: Funding must be allocated to treat drivers of HIV
If South Africa wants to strengthen the prevention arm of its HIV programme, which it definitely should, providing comprehensive sex education in schools and training teachers to deliver this curriculum will be vital. It is important that the HIV/AIDS Life Skills Grant, as one of the key pieces of a broader HIV prevention strategy, be supported and strengthened, argue Mbali Baduza and Julia Chaskalson.
Modest improvement at dysfunctional Gauteng clinics, report finds
Although a new community healthcare monitoring report notes some improvement in filling vacancies at Gauteng clinics, concerns remain over staff shortages and the impact this has on providing quality care, especially to people living with HIV. Thabo Molelekwa reports.
In-depth: New licenses could spark manufacture of COVID-19 pills in Africa
Pharmaceutical companies Merck and Pfizer recently announced early results from clinical trials showing that two new antiviral medicines are highly effective in reducing COVID-19 deaths and hospitalisation. The Medicines Patent Pool then announced licensing deals with both companies that will allow for generic versions of the two drugs to be produced. Catherine Tomlinson unpacks the licenses and asks whether generic versions of these pills might now be made in Africa.